FBIO Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.

$2.49  +0.07 (2.89%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/19/2011
Outstanding shares:  99,629,396
Average volume:  420,073
Market cap:   $241,103,138
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    34960Q109
ISIN:        US34960Q1094
Sedol:      BWT3FG4
Valuation   (See tab for details)
PE ratio:   -6.45
PB ratio:   2.65
PS ratio:   3.84
Return on equity:   -29.89%
Net income %:   -101.15%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy